BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 23340031)

  • 1. Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy).
    Cubeddu RJ; Palacios IF; Blankenship JC; Horvath SA; Xu K; Kovacic JC; Dangas GD; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Stone GW; Mehran R
    Am J Cardiol; 2013 Apr; 111(7):946-54. PubMed ID: 23340031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial.
    Fiocca L; Guagliumi G; Rossini R; Parise H; Musumeci G; Sirbu V; Lortkipanidze N; Yu J; Mihalcsik L; Vassileva A; Valsecchi O; Gavazzi A; Mehran R; Stone GW
    Am J Cardiol; 2013 Jan; 111(2):196-201. PubMed ID: 23111141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Suh JW; Mehran R; Claessen BE; Xu K; Baber U; Dangas G; Parise H; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    J Am Coll Cardiol; 2011 Oct; 58(17):1750-6. PubMed ID: 21996385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-elevation myocardial infarction mortality in a major academic center "on-" versus "off-" hours.
    Cubeddu RJ; Cruz-Gonzalez I; Kiernan TJ; Truong QA; Rosenfield K; Leinbach RC; Cadigan ME; Pomerantsev EV; Palacios IF
    J Invasive Cardiol; 2009 Oct; 21(10):518-23. PubMed ID: 19805838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of time of presentation on the care and outcomes of acute myocardial infarction.
    Jneid H; Fonarow GC; Cannon CP; Palacios IF; Kilic T; Moukarbel GV; Maree AO; LaBresh KA; Liang L; Newby LK; Fletcher G; Wexler L; Peterson E;
    Circulation; 2008 May; 117(19):2502-9. PubMed ID: 18427127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    JACC Cardiovasc Interv; 2012 Dec; 5(12):1231-8. PubMed ID: 23257371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial.
    Blankenship JC; Skelding KA; Scott TD; Berger PB; Parise H; Brodie BR; Witzenbichler B; Gaugliumi G; Peruga JZ; Lansky AJ; Mehran R; Stone GW
    Am J Cardiol; 2010 Dec; 106(11):1527-33. PubMed ID: 21094350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).
    Brener SJ; Brodie BR; Guerchicoff A; Witzenbichler B; Guagliumi G; Xu K; Mehran R; Stone GW
    Am J Cardiol; 2014 Oct; 114(7):962-7. PubMed ID: 25118121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: a report from the American Heart Association: Mission Lifeline program.
    Dasari TW; Roe MT; Chen AY; Peterson ED; Giugliano RP; Fonarow GC; Saucedo JF
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):656-63. PubMed ID: 25074371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).
    Larsen AI; Nilsen DW; Yu J; Mehran R; Nikolsky E; Lansky AJ; Caixeta A; Parise H; Fahy M; Cristea E; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Stone GW
    Am J Cardiol; 2013 Mar; 111(5):643-8. PubMed ID: 23261001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
    D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
    Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.